CJC-1295 in Matsuzaki — GHRH Analog Research Guide
CJC-1295 research guide for Matsuzaki. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.
CJC-1295 isn't stocked on pharmacy shelves in Matsuzaki or virtually any local market — it's a research compound available through a dedicated online market. This global online supply model is ultimately a quality advantage — top vendors compete on lab-verified purity in ways brick-and-mortar outlets simply cannot. A legitimate CJC-1295 supplier's COA needs to show HPLC purity, mass spectrometry confirmation of molecular identity, bacterial endotoxin testing, and a residual solvents panel — all batch-matched to your order. What follows is a sourcing and quality evaluation guide built specifically around CJC-1295, covering everything a Matsuzaki researcher needs before placing a first order.
CJC-1295: What the Research Shows
The selectivity profile of different GHS compounds is a critical research consideration. GHRP-6 and GHRP-2 produce GH release alongside cortisol and prolactin elevation — a confounding factor in research designs where these hormones are outcome variables. Ipamorelin was specifically developed for greater GH-release selectivity with minimal cortisol and prolactin elevation, making it more suitable for research designs where GH-specific effects need to be isolated. Hexarelin has the strongest GH-releasing potency in the GHRP class but also the most significant cortisol and prolactin effects. For Matsuzaki researchers designing GH-axis studies, compound selection based on this selectivity profile should precede protocol finalization.
Sourcing Research-Grade CJC-1295
Quality CJC-1295 sourcing begins with a simple filter: does this vendor share complete COA data without being asked? Those who make this data freely available are operating transparently. The HPLC chromatogram is the most important document in the COA: it should show a dominant main peak representing CJC-1295, with negligible secondary peaks representing impurities — purity should be stated as ≥98%. For Matsuzaki researchers evaluating unfamiliar vendors: a modest first purchase to test the product before scaling up your order is the accepted approach among experienced researchers. The powdered lyophilised form of CJC-1295 is always preferable to liquid pre-made solutions — lyophilised powder retains potency for years in frozen storage, while liquid preparations degrade within weeks even when refrigerated.
Order CJC-1295 — ships to Matsuzaki
COA-verified · International tracking · Research grade
All use of CJC-1295 in Matsuzaki or anywhere constitutes research use — this compound is not approved for human therapeutic use, and all handling should follow research laboratory protocols. Reconstitute CJC-1295 with bacteriostatic water at a concentration matched to your dosing requirements; a standard 5mg vial with 2mL bac water yields 2.5mg/mL — equivalent to 25mcg per unit on an insulin syringe. Quality CJC-1295 sourcing is not separable from research safety — bacterial endotoxin contamination, incorrect identity, and breakdown products are all safety issues that rigorous vendor evaluation eliminates. For any individual considering CJC-1295 outside a formal research context: speak with a healthcare professional — this compound is not approved for human use and its known risks are not comparable to approved pharmaceuticals.
Frequently Asked Questions
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
